Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Randolph Medical Associates
mi
from
Asheboro, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Randolph Medical Associates
mi
from
Asheboro, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Detweiler Family Medicine
mi
from
Lansdale, PA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Detweiler Family Medicine
mi
from
Lansdale, PA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
The Endocrine Center
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
The Endocrine Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Bandera Family Health Clinic
mi
from
San Antonio, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Bandera Family Health Clinic
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
North America Research Institute Inc.
mi
from
San Dimas, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
North America Research Institute Inc.
mi
from
San Dimas, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Southeastern Clinical Research Institute, LLC
mi
from
Augusta, GA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Southeastern Clinical Research Institute, LLC
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Iowa Diabetes and Endocrinology Research
mi
from
West Des Moines, IA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Iowa Diabetes and Endocrinology Research
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
My Kidney Center, LLC
mi
from
Manhattan, KA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
My Kidney Center, LLC
mi
from
Manhattan, KA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Four Rivers Clincial Research
mi
from
Paducah, KY
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Four Rivers Clincial Research
mi
from
Paducah, KY
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Biolab Research, LLC
mi
from
Rockville, MD
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Biolab Research, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Elite Research Center LLC
mi
from
Flint, MI
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Elite Research Center LLC
mi
from
Flint, MI
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Seacost Kidney & Hypertension
mi
from
Portsmouth, NH
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Seacost Kidney & Hypertension
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Brookview Hills Research
mi
from
Winston-Salem, NC
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Brookview Hills Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc./Oklahoma City Clinic
mi
from
Oklahoma City, OK
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc./Oklahoma City Clinic
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
The Medical Group of Texas
mi
from
Fort Worth, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
The Medical Group of Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Houston Nephrology Research
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Houston Nephrology Research
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Arizona Kidney Disease and Hypertension Center
mi
from
Flagstaff, AZ
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Arizona Kidney Disease and Hypertension Center
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Comprehensive Research Institute
mi
from
Alhambra, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Comprehensive Research Institute
mi
from
Alhambra, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Diabetes and Endocrinology Clinical Consultants of Texas
mi
from
Dallas, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Diabetes and Endocrinology Clinical Consultants of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Thyroid Disease and Chronic Periodontitis
Thyroid Insufficiency as a Modifying Factor for Chronic Periodontitis
Status: Enrolling
Updated:  12/31/1969
School of Dental Medicine, University at Buffalo
mi
from
Buffalo, NY
Thyroid Disease and Chronic Periodontitis
Thyroid Insufficiency as a Modifying Factor for Chronic Periodontitis
Status: Enrolling
Updated: 12/31/1969
School of Dental Medicine, University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
Status: Enrolling
Updated:  12/31/1969
2DKB
mi
from
Minsk,
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
Status: Enrolling
Updated: 12/31/1969
2DKB
mi
from
Minsk,
Click here to add this to my saved trials
The Effects of Chia on Overweight/Obese Women
Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
Status: Enrolling
Updated:  12/31/1969
California State Polytechnic University, Pomona
mi
from
Pomona, CA
The Effects of Chia on Overweight/Obese Women
Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
Status: Enrolling
Updated: 12/31/1969
California State Polytechnic University, Pomona
mi
from
Pomona, CA
Click here to add this to my saved trials
Effects of Almonds on Insulin Sensitivity in Prediabetes
A Randomized, Crossover Trial to Assess the Effects of Replacing Refined Carbohydrates With Almonds on Insulin Sensitivity in Men and Women With Prediabetes.
Status: Enrolling
Updated:  12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Effects of Almonds on Insulin Sensitivity in Prediabetes
A Randomized, Crossover Trial to Assess the Effects of Replacing Refined Carbohydrates With Almonds on Insulin Sensitivity in Men and Women With Prediabetes.
Status: Enrolling
Updated: 12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Effects of Almonds on Insulin Sensitivity in Prediabetes
A Randomized, Crossover Trial to Assess the Effects of Replacing Refined Carbohydrates With Almonds on Insulin Sensitivity in Men and Women With Prediabetes.
Status: Enrolling
Updated:  12/31/1969
Illinois Institute for Food Safety and Health (IFSH) at Illinois Instiute of Technology (IIT)
mi
from
Chicago, IL
Effects of Almonds on Insulin Sensitivity in Prediabetes
A Randomized, Crossover Trial to Assess the Effects of Replacing Refined Carbohydrates With Almonds on Insulin Sensitivity in Men and Women With Prediabetes.
Status: Enrolling
Updated: 12/31/1969
Illinois Institute for Food Safety and Health (IFSH) at Illinois Instiute of Technology (IIT)
mi
from
Chicago, IL
Click here to add this to my saved trials
Lean Beef Consumption and Insulin Sensitivity in Men and Women With Risk Factors for Diabetes
A Randomized, Controlled-Feeding, Crossover Trial to Assess the Effects of Increasing Lean Beef Consumption Within a Healthy Dietary Pattern on Insulin Sensitivity in Men and Women With Risk Factors for Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Lean Beef Consumption and Insulin Sensitivity in Men and Women With Risk Factors for Diabetes
A Randomized, Controlled-Feeding, Crossover Trial to Assess the Effects of Increasing Lean Beef Consumption Within a Healthy Dietary Pattern on Insulin Sensitivity in Men and Women With Risk Factors for Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Dietary Approaches for Cardiometabolic Health
Dietary Approaches for Improving Cardiometabolic Health
Status: Enrolling
Updated:  12/31/1969
Institute for Clinical and Translational Science
mi
from
Irvine, CA
Dietary Approaches for Cardiometabolic Health
Dietary Approaches for Improving Cardiometabolic Health
Status: Enrolling
Updated: 12/31/1969
Institute for Clinical and Translational Science
mi
from
Irvine, CA
Click here to add this to my saved trials
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Status: Enrolling
Updated:  12/31/1969
Comprehensive Weight Control Center
mi
from
New York, NY
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Status: Enrolling
Updated: 12/31/1969
Comprehensive Weight Control Center
mi
from
New York, NY
Click here to add this to my saved trials
Impact of Screening Patients With HIV for Kidney Disease
Impact of Screening Patients With HIV for Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Impact of Screening Patients With HIV for Kidney Disease
Impact of Screening Patients With HIV for Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Azusa, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Azusa, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Yuba City, CA
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Yuba City, CA
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hudson, FL
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hudson, FL
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rockville, MD
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Buffalo, NY
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greenville, NC
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Morehead City, NC
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Statesville, NC
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
A Phase 2a, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety and Efficacy of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With an Renin-Angiotensin System Inhibitor
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Statesville, NC
Click here to add this to my saved trials